Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome
Disease Markers · 03.11.2022 · 2022 · 1-12
DOI: 10.1155/2022/2193343 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Disease Markers, erschienen am 03.11.2022. Verfasst von Zhanyi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Anemia. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Basic Research Program of China.
Abstract (Originalsprache)
Background
Previous studies have shown that increased mean corpuscular volume (MCV) is an independent predictor for worse outcomes in coronary artery disease. However, as parameters to classify different types of anemia together with MCV, the relationship between mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and long-term outcomes in acute coronary syndrome (ACS) remains obscure. Moreover, few studies have compared the prognostic value of these red blood cell indices in anemic and nonanemic patients with ACS. Methods and Results. In this single-center observational cohort study, we enrolled 393 patients diagnosed with ACS, including 75 anemic and 318 nonanemic patients. The composite end points were defined as major adverse cardiovascular events (MACEs). After a median follow-up of 31.24 months, Kaplan–Meier survival analysis showed that higher MCV and MCH but not MCHC were significantly associated with increased MACEs in nonanemic ACS patients. Among the enrolled ACS patients without anemia, Cox regression analysis revealed that high MCV and MCH were correlated with increased MACEs after adjustment for cardiovascular risk factors, and receiver operating characteristic (ROC) curve analysis further confirmed the predictive value of high MCV and MCH. In bivariate correlation and linear regression analysis, plasma homocysteine was positively correlated with MCV and MCH but not MCHC in the nonanemic group even after adjusting for age, male sex, BMI, SBP, DBP, smoking, and diabetes. However, MCV, MCH, and MCHC showed no predictive value for MACEs, and no correlation was found between these red blood cell indices and homocysteine in ACS patients with anemia.
Conclusion
After adjusting for cardiovascular risk factors, this study showed that higher admission MCV and MCH but not MCHC were independent predictors for long-term MACEs and positively correlated with homocysteine levels in the blood among the nonanemic but not anemic patients with ACS in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Key Laboratory of Molecular Cardiology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
- Health Management Center, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shaanxi, China.
ORCID-Profile: Zhanyi Zhang, Juan Zhou, Zuyi Yuan
Förderung
- National Natural Science Foundation of China
- National Basic Research Program of China
Zitieren
APA
Zhang, Z., Gao, S., Dong, M., Luo, J., Xu, C., Wen, W., Huang, Y., Wu, Y., Zhou, J., & Yuan, Z. (2022). Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome. Disease Markers, 2022, 1-12. https://doi.org/10.1155/2022/2193343
Vancouver
Zhang Z, Gao S, Dong M, Luo J, Xu C, Wen W, et al. Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome. Disease Markers. 2022;2022:1-12. doi:10.1155/2022/2193343
BibTeX
@article{Zhang2022,
author = {Zhang, Zhanyi and Gao, Shanshan and Dong, Mengya and Luo, Jian and Xu, Chenbo and Wen, Wen and Huang, Yuzhi and Wu, Yue and Zhou, Juan and Yuan, Zuyi},
title = {Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome},
journal = {Disease Markers},
year = {2022},
volume = {2022},
pages = {1--12},
doi = {10.1155/2022/2193343}
}
EUVIMED